MaaT Pharma has raised an €18 million ($20 million) series B round. The financing equips MaaT to wrap up a phase 2 trial of its lead microbiome therapy in graft-versus-host disease (GVHD) while expanding into solid tumors.

As GlaxoSmithKline announced it is splitting in two (with a consumer healthcare unit to become standalone), the British Big Pharma says its priority at GSK 2.0 will be R&D.

The FDA has approved the injection of soft hydrogel spacers designed to help firm up the walls of the urethra in women with stress urinary incontinence. By supporting the urethra’s volume and increasing its natural closing pressure, the injections aim to prevent urine leakage during daily activities.

Rachel Humphrey, M.D., quietly and abruptly left CytomX Therapeutics last August as its chief medical officer; now, the cancer biotech has finally hired a new CMO.

Following the FDA’s successive clearances of new, reprocessing-conscious duodenoscope designs from Pentax Medical and Boston Scientific late last year, competitor Olympus Medical has now received a green light of its own.

Four years after Andreessen Horowitz raised its first bio fund, the VC shop is launching its third biotech- and healthcare-focused fund. At $750 million, Bio Fund III is a16z’s biggest fund of its kind yet, and it will bankroll early-stage companies, though General Partner Jorge Conde said it will “selectively” participate in more mature companies too.

Multinational conglomerate Sony has received a clearance from the FDA for its digital workflow collaboration platform for hospital operating rooms and catheter labs.

Researchers at the University of Michigan are working on a noninvasive method to check whether brain cells are in distress—a tool that could alert people to seek medical attention earlier after receiving a concussion.

It took less than a year to develop the drug, which is designed to treat OCD.

A 3D-printed polyester rabbit has been embedded with DNA that contains a blueprint for printing additional bunnies. Using the information, researchers have replicated the rabbit several times, highlighting the potential for using DNA to store information in everyday objects.